NNP
GMED icon

Nachman Norwood & Parrott’s Globus Medical GMED Stock Holding History

Nachman Norwood & Parrott’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-259
Closed -$13K – 563
2020
Q3 		$13K Buy
+259
New +$13.4K ﹤0.01% 703

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Nachman Norwood & Parrott's GMED Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Globus Medical (GMED) in Q4 2020, closing a stake of 259 shares — an estimated $13K sold.

Nachman Norwood & Parrott first reported a position in GMED in Q3 2020 and held it in 1 quarter. The position peaked at $13K in Q3 2020. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Globus Medical position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 259 Globus Medical shares in Q4 2020, an estimated $13K.
  • Nachman Norwood & Parrott first reported a position in Globus Medical in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Globus Medical position peaked at $13K in Q3 2020.
  • 348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.